These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 21938743)
1. Glycosilated nucleolin as marker for human gliomas. Galzio R; Rosati F; Benedetti E; Cristiano L; Aldi S; Mei S; D'Angelo B; Gentile R; Laurenti G; Cifone MG; Giordano A; Cimini A J Cell Biochem; 2012 Feb; 113(2):571-9. PubMed ID: 21938743 [TBL] [Abstract][Full Text] [Related]
2. Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells. Niu CS; Li DX; Liu YH; Fu XM; Tang SF; Li J Oncol Rep; 2011 Sep; 26(3):593-601. PubMed ID: 21573506 [TBL] [Abstract][Full Text] [Related]
3. Nucleolin is expressed in patient-derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity. Balça-Silva J; do Carmo A; Tão H; Rebelo O; Barbosa M; Moura-Neto V; Sarmento-Ribeiro AB; Lopes MC; Moreira JN Exp Cell Res; 2018 Sep; 370(1):68-77. PubMed ID: 29902537 [TBL] [Abstract][Full Text] [Related]
4. Functions of the histone chaperone nucleolin in diseases. Storck S; Shukla M; Dimitrov S; Bouvet P Subcell Biochem; 2007; 41():125-44. PubMed ID: 17484127 [TBL] [Abstract][Full Text] [Related]
5. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes. Jin F; Zhao L; Zhao HY; Guo SG; Feng J; Jiang XB; Zhang SL; Wei YJ; Fu R; Zhao JS Neuroscience; 2008 Jun; 154(2):541-50. PubMed ID: 18462887 [TBL] [Abstract][Full Text] [Related]
6. Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest. Xu Z; Joshi N; Agarwal A; Dahiya S; Bittner P; Smith E; Taylor S; Piwnica-Worms D; Weber J; Leonard JR J Neurooncol; 2012 May; 108(1):59-67. PubMed ID: 22382782 [TBL] [Abstract][Full Text] [Related]
7. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays. He J; Liu Y; Zhu T; Zhu J; Dimeco F; Vescovi AL; Heth JA; Muraszko KM; Fan X; Lubman DM Mol Cell Proteomics; 2012 Jun; 11(6):M111.010744. PubMed ID: 22203689 [TBL] [Abstract][Full Text] [Related]
8. Presence of pluripotent CD133+ cells correlates with malignancy of gliomas. Thon N; Damianoff K; Hegermann J; Grau S; Krebs B; Schnell O; Tonn JC; Goldbrunner R Mol Cell Neurosci; 2010 Jan; 43(1):51-9. PubMed ID: 18761091 [TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of JAM-A in gliomas. Rosager AM; Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Lathia JD; Kristensen BW J Neurooncol; 2017 Oct; 135(1):107-117. PubMed ID: 28677106 [TBL] [Abstract][Full Text] [Related]
10. Limits of CD133 as a marker of glioma self-renewing cells. Clément V; Dutoit V; Marino D; Dietrich PY; Radovanovic I Int J Cancer; 2009 Jul; 125(1):244-8. PubMed ID: 19350631 [TBL] [Abstract][Full Text] [Related]
11. B7-H4 expression is elevated in human U251 glioma stem-like cells and is inducible in monocytes cultured with U251 stem-like cell conditioned medium. Mo LJ; Ye HX; Mao Y; Yao Y; Zhang JM Chin J Cancer; 2013 Dec; 32(12):653-60. PubMed ID: 23327799 [TBL] [Abstract][Full Text] [Related]
12. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas. Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792 [TBL] [Abstract][Full Text] [Related]
13. B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells. Yao Y; Tao R; Wang X; Wang Y; Mao Y; Zhou LF Neuro Oncol; 2009 Dec; 11(6):757-66. PubMed ID: 19264916 [TBL] [Abstract][Full Text] [Related]
14. Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade. Zhu C; Kros JM; van der Weiden M; Zheng P; Cheng C; Mustafa DA Acta Neuropathol Commun; 2017 Jan; 5(1):4. PubMed ID: 28073370 [TBL] [Abstract][Full Text] [Related]
15. Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolin. Bhatia S; Reister S; Mahotka C; Meisel R; Borkhardt A; Grinstein E Leukemia; 2015 Nov; 29(11):2208-20. PubMed ID: 26183533 [TBL] [Abstract][Full Text] [Related]
16. A fucose-containing O-glycoepitope on bovine and human nucleolin. Aldi S; Della Giovampaola C; Focarelli R; Armini A; Ziche M; Finetti F; Rosati F Glycobiology; 2009 Apr; 19(4):337-43. PubMed ID: 19023103 [TBL] [Abstract][Full Text] [Related]
17. Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients. Chen C; Chen L; Yao Y; Qin Z; Chen H J Neurooncol; 2016 Mar; 127(1):43-52. PubMed ID: 26615563 [TBL] [Abstract][Full Text] [Related]
18. Nucleolar localization of aprataxin is dependent on interaction with nucleolin and on active ribosomal DNA transcription. Becherel OJ; Gueven N; Birrell GW; Schreiber V; Suraweera A; Jakob B; Taucher-Scholz G; Lavin MF Hum Mol Genet; 2006 Jul; 15(14):2239-49. PubMed ID: 16777843 [TBL] [Abstract][Full Text] [Related]
19. Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures. Aaberg-Jessen C; Nørregaard A; Christensen K; Pedersen CB; Andersen C; Kristensen BW Int J Clin Exp Pathol; 2013; 6(4):546-60. PubMed ID: 23573302 [TBL] [Abstract][Full Text] [Related]
20. The pathological characteristics of glioma stem cell niches. He H; Li MW; Niu CS J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]